Unity Biotechnology, Inc.

Unity Biotechnology, Inc.

Unity Biotechnology, Inc.

Overview
Date Founded

2009

Headquarters

3280 Bayshore Boulevard,Suite 100,Brisbane, CA 95002

Type of Company

Public

Employees (Worldwide)

98

Industries

Biotechnology
Medical Support Services
Hospitals & Patient Services

Company Description

Unity Biotechnology, Inc. operates as a biotechnology company engaged in the research and development of therapeutics to extend the human health span. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi and Daohong Zhou on March 30, 2009 and is headquartered in Brisbane, CA.

Contact Data
Trying to get in touch with decision makers at Unity Biotechnology, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder & President

Founder

Founder

Founder

Chief Executive Officer

Chief Financial & Accounting Officer

General Counsel

Chief Scientific Officer

Chief Medical Officer

Senior Vice President of Operations

Paths to Unity Biotechnology, Inc.
Potential Connections via
Relationship Science
You
Unity Biotechnology, Inc.
Owners & Shareholders
Details Hidden

Mayo Clinic Ventures focuses on the commercialization of discoveries and inventions made by Mayo Clinic physicians and employees. The firm invests primarily in the healthcare-related fields: research tools, diagnostics, therapeutics, medical devices, electronic devices and software.

Details Hidden

Invus Financial Advisors is a sister firm of The Invus Group LLC. Invus is a New York based investment firm with additional offices in London, Paris and Hong Kong. Invus invests in a variety of equity transactions, including buyouts, longer term public equity investments, venture capital, and expansion financings. Invus manages in excess of $4 billion of capital.

Details Hidden

Asymmetry Capital Management seeks to deliver absolute, risk-adjusted returns across market cycles by investing in a value-oriented, diversified, global portfolio of healthcare companies. The firm's objective is to generate returns on both long and short positions with moderate to low net exposure and low correlations to broad equity and healthcare-related indices. Asymmetry also focuses on maximizing positive and sustainable impacts on ESG (environment, social and governance) and responsible investing.

Recent Transactions
Details Hidden

Unity Biotechnology, Inc. issued USD Common Stock

Details Hidden

Unity Biotechnology, Inc. raised money in a private placement transaction

Details Hidden

Unity Biotechnology, Inc. raised money in a private placement transaction

Transaction Advisors
Underwriter

Advised onUnity Biotechnology, Inc. issued USD Common Stock

Escrow Agent

Advised onUnity Biotechnology, Inc. issued USD Common Stock

Underwriter

Advised onUnity Biotechnology, Inc. issued USD Common Stock

Legal Advisor

Advised onUnity Biotechnology, Inc. issued USD Common Stock

Legal Advisor

Advised onUnity Biotechnology, Inc. issued USD Common Stock

Legal Advisor

Advised onUnity Biotechnology, Inc. issued USD Common Stock

Advisors & Consultants
Consultant

Chief Financial & Accounting Officer at Unity Biotechnology, Inc.

Key Stats and Financials As of 2019
Market Capitalization
$250M
Total Enterprise Value
$187M
Earnings Per Share
$-1.88
Debt TEV
0x
TEVNet Income
-2.28x
Total Equity
$121M
Total Debt
$45K
EBITDA
$-88.3M
Net Profit
$-82.2M
Revenue
$0
Investors
Details Hidden

Mayo Clinic Ventures focuses on the commercialization of discoveries and inventions made by Mayo Clinic physicians and employees. The firm invests primarily in the healthcare-related fields: research tools, diagnostics, therapeutics, medical devices, electronic devices and software.

Details Hidden

Invus Financial Advisors is a sister firm of The Invus Group LLC. Invus is a New York based investment firm with additional offices in London, Paris and Hong Kong. Invus invests in a variety of equity transactions, including buyouts, longer term public equity investments, venture capital, and expansion financings. Invus manages in excess of $4 billion of capital.

Details Hidden

Vulcan ventures Inc seeks investment opportunities in companies located in the US. The firm focuses on companies with an experienced management team, recurring revenues and substantial free cash flows. It targets companies operating in the fields of media conglomerates, energy minerals, financial services, healthcare services, life science and communication. It provides financing for early stage capital requirements.

Suppliers
Buck Institute for Research on Aging Biotechnology | Novato, CA

The Buck Institute is the nation’s first independent research facility focused solely on understanding the connection between aging and chronic disease. Our mission is to increase the healthy years of life. At the Buck Institute, world-class scientists work in a uniquely collaborative environment to understand how normal aging contributes to the development of conditions specifically associated with getting older such as Alzheimer’s and Parkinson’s diseases, cancer, stroke, osteoporosis, heart disease, diabetes, macular degeneration and glaucoma. Our interdisciplinary approach brings scientists from disparate fields together to develop diagnostic tests and treatments to prevent or delay these maladies.

Ascentage Pharma Group International Co., Ltd. Pharmaceuticals | Suzhou, China

Ascentage Pharma Group International Co., Ltd. develops and produces pharmaceutical products. The company was founded by Dajun Yang and Ming Guo and is headquartered in Shanghai, China.

Mayo Clinic Hospitals & Patient Services | Rochester, MN

The Mayo Clinic is a nonprofit academic medical center based in Rochester, Minnesota, focused on integrated clinical practice, education, and research. It employs more than 4,500 physicians and scientists and 58,400 administrative and allied health staff. The practice specializes in treating difficult cases through tertiary care. It spends over $660 million a year on research and employs over 3,000 full-time research personnel.

Competitors
Regeneron Pharmaceuticals, Inc. Pharmaceuticals - Tarrytown, New York

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Alphabet, Inc. Internet Software & Services - Mountain View, CA

Alphabet, Inc. is a holding company, which engages in the business of acquisition and operation of different companies. It operates through the Google and Other Bets segments. The Google segment includes its main Internet products such as ads, Android, Chrome, hardware, Google Cloud, Google Maps, Google Play, Search, and YouTube. The Other Bets segment consists of businesses such as Access, Calico, CapitalG, GV, Verily, Waymo, and X. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Unity Biotechnology, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Unity Biotechnology, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Unity Biotechnology, Inc..